Trials / Withdrawn
WithdrawnNCT04082741
A Single and Multiple Ascending Dose Study of BMS-986318 in Healthy Participants
A Phase 1, Double-Blind, Placebo-Controlled, Randomized Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Exploratory Pharmacodynamics of Oral BMS-986318 Administration in Healthy Participants
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A study to evaluate single and multiple ascending doses of experimental medicine BMS-986318 in healthy participants.
Detailed description
A Phase 1, Double-Blind, Placebo-Controlled, Randomized Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Exploratory Pharmacodynamics of Oral BMS-986318 Administration in Healthy Participants
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986318 | Specified dose on specified days |
| OTHER | Placebo | Placebo Matching BMS-986318 |
Timeline
- Start date
- 2019-07-18
- Primary completion
- 2019-09-12
- Completion
- 2019-09-12
- First posted
- 2019-09-09
- Last updated
- 2020-01-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04082741. Inclusion in this directory is not an endorsement.